Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced that as part of its strategic plan to evolve into a forward-integrated biopharmaceutical company, Brian O’Callaghan has been appointed chief executive officer (CEO) and member of the board of directors. Mr. O’Callaghan,...
Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
AIT365 News Desk -
Logica, an offering from Charles River and Valo Health, will be used to discover first-in-class therapeutics against high value targets in the Related Sciences portfolio
Charles River Laboratories International, Inc. and Related Sciences, a data science-driven drug discovery firm, announced a multi-program collaboration agreement to apply Logica™ across several previously undrugged...
Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics
AIT365 News Desk -
Generate:Biomedicines, a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform, announced that it has raised $273 million in Series C financing. This financing round attracted many new investors including Amgen; NVentures, NVIDIA’s venture capital arm; MAPS Capital; and Pictet Alternative Advisors. Additionally, company founder, Flagship Pioneering, and every...
SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM™ Platform and will use the technology to deploy a new test that will...
Infleqtion, UChicago, and MIT Unite to Develop Breakthrough Cancer Solutions with AI and Quantum Algorithms
AIT365 News Desk -
Infleqtion, the world's quantum information company, announced that it had been awarded funding from Wellcome Leap's Quantum for Bio (Q4Bio) program with a team of renowned researchers and medical doctors at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT). This collaborative effort aims to transform cancer care by harnessing the power...
BenevolentAI, a leader in the development of advanced AI that accelerates biopharma discovery, announces the appointment of Catherine Isted, ACMA, who will be joining the Company as Chief Financial Officer with immediate effect.
Catherine is an experienced strategic finance professional and chartered accountant with over 25 years within the life...
HumanFirst Launches New Enterprise Platform to Accelerate Adoption of Precision Measures and Artificial Intelligence in Clinical Research
AIT365 News Desk -
HumanFirst, a cloud-based software company accelerating patient-centered drug development through AI-powered insights, announced the launch of the industry's first-of-its-kind precision measures platform. HumanFirst's platform enables pharma and biotechs to reliably incorporate patient-centric measures and validated technologies into clinical research.
With life science organizations under pressure to increase R&D efficiency and...
Biocom California Institute Partners with Regional Workforce Development Board NOVAworks to Support the Life Science Workforce
AIT365 News Desk -
Biocom California Institute, a 501(c)(3) non-profit that supports life science innovation by strengthening the workforce and leaders of tomorrow, announced a partnership with NOVAworks, a nonprofit regional workforce development agency in San Mateo and northern Santa Clara counties. Multiple initiatives will be employed through the new partnership to help...